Pale Fire Capital Se Galera Therapeutics, Inc. Transaction History

Pale Fire Capital Se

  • $887 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.17 - $3.0 $2,958 - $52,200
17,400 New
17,400 $3.05 Million

Others Institutions Holding GRTX

# of Institutions
3
Shares Held
961K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.34M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email